Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Exploring hTERT promoter methylation in cutaneous T-cell lymphomas.
Chebly A, Ropio J, Peloponese JM, Poglio S, Prochazkova-Carlotti M, Cherrier F, Ferrer J, Idrissi Y, Segal-Bendirdjian E, Chouery E, Farra C, Pham-Ledard A, Beylot-Barry M, Merlio JP, Tomb R, Chevret E. Chebly A, et al. Among authors: poglio s. Mol Oncol. 2022 May;16(9):1931-1946. doi: 10.1002/1878-0261.12946. Epub 2021 Oct 12. Mol Oncol. 2022. PMID: 33715271 Free PMC article.
Molecular alterations and tumor suppressive function of the DUSP22 (Dual Specificity Phosphatase 22) gene in peripheral T-cell lymphoma subtypes.
Mélard P, Idrissi Y, Andrique L, Poglio S, Prochazkova-Carlotti M, Berhouet S, Boucher C, Laharanne E, Chevret E, Pham-Ledard A, De Souza Góes AC, Guyonnet-Duperat V, Bibeyran A, Moreau-Gaudry F, Vergier B, Beylot-Barry M, Merlio JP, Cappellen D. Mélard P, et al. Among authors: poglio s. Oncotarget. 2016 Oct 18;7(42):68734-68748. doi: 10.18632/oncotarget.11930. Oncotarget. 2016. PMID: 27626696 Free PMC article.
TP53 alterations in primary and secondary Sézary syndrome: A diagnostic tool for the assessment of malignancy in patients with erythroderma.
Gros A, Laharanne E, Vergier M, Prochazkova-Carlotti M, Pham-Ledard A, Bandres T, Poglio S, Berhouet S, Vergier B, Vial JP, Chevret E, Beylot-Barry M, Merlio JP. Gros A, et al. Among authors: poglio s. PLoS One. 2017 Mar 16;12(3):e0173171. doi: 10.1371/journal.pone.0173171. eCollection 2017. PLoS One. 2017. PMID: 28301507 Free PMC article.
Targeting Epigenetic Modifiers Can Reduce the Clonogenic Capacities of Sézary Cells.
Chebly A, Prochazkova-Carlotti M, Idrissi Y, Bresson-Bepoldin L, Poglio S, Farra C, Beylot-Barry M, Merlio JP, Tomb R, Chevret E. Chebly A, et al. Among authors: poglio s. Front Oncol. 2021 Oct 26;11:775253. doi: 10.3389/fonc.2021.775253. eCollection 2021. Front Oncol. 2021. PMID: 34765562 Free PMC article.
Cutaneous Lymphocyte Antigen Is a Potential Therapeutic Target in Cutaneous T-Cell Lymphoma.
Peru S, Prochazkova-Carlotti M, Cherrier F, Velazquez J, Richard E, Idrissi Y, Cappellen D, Azzi-Martin L, Pham-Ledard A, Beylot-Barry M, Merlio JP, Poglio S. Peru S, et al. Among authors: poglio s. J Invest Dermatol. 2022 Dec;142(12):3243-3252.e10. doi: 10.1016/j.jid.2022.06.016. Epub 2022 Jul 16. J Invest Dermatol. 2022. PMID: 35850209 Free article.
Patient-Derived Xenograft and Cell Line Models of Human Primary Cutaneous Diffuse Large B-Cell Lymphoma-Leg Type.
Prochazkova-Carlotti M, Gros A, Richard E, Cherrier F, Laharanne E, Idrissi Y, Baron C, Poglio S, Ducharme O, Menguy S, Pham-Ledard A, Beylot-Barry M, Merlio JP, Bresson-Bepoldin L. Prochazkova-Carlotti M, et al. Among authors: poglio s. J Invest Dermatol. 2023 Feb;143(2):340-344.e6. doi: 10.1016/j.jid.2022.08.043. Epub 2022 Sep 7. J Invest Dermatol. 2023. PMID: 36084691 Free article. No abstract available.
28 results